期刊文献+

表达戊型肝炎病毒ORF2蛋白的重组腺病毒构建及其经粘膜途径免疫小鼠 被引量:3

Construction of a Recombinant Human Adenovirus Expressing the ORF2 Antigen of HEV and Immunization of Mice by Mucosal System
下载PDF
导出
摘要 目的构建可表达戊型肝炎病毒(hepatitisEvirus,HEV)ORF2蛋白(112-660aa)的重组腺病毒Adasy-EORF2,探讨其经鼻腔和腹腔免疫小鼠后,诱导机体产生特异性体液免疫和粘膜免疫应答的能力,为研制戊型肝炎疫苗探索新的途径。方法经PCR扩增编码ORF2蛋白(112-660aa)的基因片段,将其连接于重组腺病毒Adasy系统的穿梭质粒pTrack-CMV上,与腺病毒基因组质粒pAdEasy-1共转化宿主菌BJ5183,经细菌内同源重组获得重组腺病毒基因组质粒,转染293细胞以产生、扩增重组腺病毒。将重组腺病毒以107pfu的剂量经鼻腔和腹腔免疫小鼠,通过ELISA检测血液IgG和粘膜IgA的应答情况。结果重组腺病毒经鼻腔免疫小鼠后可刺激机体产生特异性IgA、IgG免疫应答,IgG最高滴度达1∶1000。经腹腔免疫可刺激小鼠产生IgG免疫应答,最高滴度可达1∶10000,未检测到明显的IgA应答。结论表达HEVORF2蛋白的重组腺病毒能刺激机体产生有效的免疫应答,具有成为新型戊型肝炎疫苗的潜力。 Objective To construct a replication-defective recombinant adenovirus expressing the ORF2(112-660aa)antigen of hepatitis E virus(HEV)and evaluate its immunization effect in BALB/c mice by mucosal inoculation.Methods The HEV ORF2gene encoding for112-660aa was amplified from plasmid pUC-HEV and inserted into the transfer vector pTrack-CMV.The recombinant plasmid and adenoviral backbone plasmid pAdEasy-1were co-transformed into E.coli strain BJ5183.Taking the advantage of the high efficient homologous recombination machinery presented in bacteria,the recombinant adenovirus backbone plasmid was generated in BJ5183,and then was transfected into293cells.Recombinant Adenoviruses were propagated in293cells with high titers.8-week-old BALB/c mice were inoculated intraperitoneally and intranasally with10 7 pfu recombinant adenovirus each on weeks0,3,5,7,10.Results Both groups of mice induced humoral IgG immune response with the highest titers1∶1000and1∶10000each.Only the group inoculated intranasally could induce mucosal IgA immune response.Conclusions The adenoviral recombinant can stimulate specific humoral and mucosal immune response in mice and is potentialy to be used as a candidate vaccine for the treatment of HEV infection.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2003年第3期324-328,共5页 Acta Academiae Medicinae Sinicae
关键词 重组腺病毒 戊型肝炎病毒 疫苗 recombinant adenovirus hepatitis E virus vaccine
  • 相关文献

参考文献9

  • 1何金生,王健伟,温乐英,徐倏焱木,屈建国,姜慧英,洪涛.用重组腺病毒表达A组轮状病毒主要中和抗原VP7可获得良好的免疫学效果[J].病毒学报,2001,17(2):122-126. 被引量:18
  • 2Clements ML, Betts RF, Tiemey EL, et al. Serum and nasal wash antibodies associated with resistance to experimental challenge with influence a wi]cl-type virus. J Clin Microbiol, 1986, 24:157-160.
  • 3Christine BB, Man A, Sally AS, et al. Replication-defective recombinant adenovirus expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice. J General Virol, 1999, 80:2621-2628.
  • 4He TC, Zhou S, Costa LT, et al. A simplified system for generating recombinant adenovirus. Pro Natl Acad Sci USA,1998, 95:2509-2514.
  • 5Xiang Z, Hildegund CJE. Induction of mucosal immunity with a replicationdefective adenoviral recombinant. Vaccine,1999, 17:2003-2008.
  • 6Jihong M, Xing D, Joy C, et al. Identification and characterization of the neutralization epitope (s) of the hepatitis E virus, Virol, 2001, 288:203-211.
  • 7Li TC, Yamakawa Y, Suzuki K, et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol, 1997, 71:7207-7213.
  • 8Li TC, Naokazu T, Tatsuo M. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine, 2001, 19:3476-3484.
  • 9Harvey BG, Neil RH, Tarek E, et al. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administrated to different organs. J Virol, 1992, 99:6719-6742.

二级参考文献1

共引文献17

同被引文献44

  • 1苏彩霞,顾美荣,张萍,金贞姬,孟凡红,陈尔佳,杨喆,刘勇,王佑春.戊型肝炎病毒Ⅳ型ORF2蛋白在汉逊酵母中的表达[J].生物工程学报,2007,23(1):73-78. 被引量:12
  • 2Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India [J]. J Viral Hepat 2003; 10: 224-31.
  • 3Shrestha SM, Shrestha S, Tsuda F, et al. Molecular investigation of hepatitis E virus infection in patients with acute hepatitis E in Kathmandu [J] .Nepal. J Med Virol 2003; 69:207 - 14.
  • 4Isaaecson M, Frean J, He J, et al. An outbreak of hepatitis E in northern Namibia [J] .Am J Trop Med Hyg 2000; 62: 619-25.
  • 5Labrique AB, Thomas DL, Stoszek SK, et al. Hdpatitis E: an emerging infectious disease [J]. Epidemiol Rev 1999; 21: 162-79.
  • 6Ghabrah TM, Tsarev S, Yarbough PO, et al. Comparison of tests for antibody to hepatitis E virus [J]. J Med Virol 1998; 55: 134-7.
  • 7Khudyakov YE, Lopareva EN, Jue DL, et al. Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus [J]. J Clin Microbiol 1999; 37:2863-71.
  • 8Meng J, Dai X, Chang JC, et al. Identification and characterization of the neutralizing epitope (s) of the hepatitis E virus [J]. Virology2001; 288: 203-11.
  • 9PurdyMA, McCaustlandKA, KrawczynskiK, et al. Preliminary evidence that a trp E-HEV fusion protein protects cynomolgus macaques against challenge with the wild-type hepatitis E virus (HEV) [J]. J Med Virol 1993; 41: 90-4.
  • 10ImSW, ZhangJZ, Zhuang H, et al. A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus[J]. Vaccine2001; 19: 3726-32.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部